| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/01/2010 | WO2010036392A1 Organic acid free effervescent formulation |
| 04/01/2010 | WO2010036211A1 A process for making particles for delivery of drug nanoparticles |
| 04/01/2010 | WO2010035656A1 Oral preparation |
| 04/01/2010 | WO2010035327A1 Process for producing soft capsule and apparatus for producing the same |
| 04/01/2010 | WO2010035273A2 Novel gastroretentive delivery system |
| 04/01/2010 | WO2010035245A2 Extended release dosage form of ropinirole |
| 04/01/2010 | WO2010035081A1 Method and system for reshaping the cornea |
| 04/01/2010 | WO2010034901A2 Gel adapted for transmitting ultrasound waves, method for making said gel, and bag containing same |
| 04/01/2010 | WO2010034837A1 Method of solubilising biologically active compounds |
| 04/01/2010 | WO2010034763A1 Bandage for joint pain treatment comprising at least two transdermal patches |
| 04/01/2010 | WO2010034688A2 Use of polyether-based and vinyl monomer-based copolymers as binders for dosing forms comprising solid active ingredients |
| 04/01/2010 | WO2010034497A2 Compacted cinacalcet |
| 04/01/2010 | WO2010034425A1 Multiparticulate tablet and method for the production thereof |
| 04/01/2010 | WO2010034344A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 04/01/2010 | WO2010034342A1 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 04/01/2010 | WO2010034319A1 Magnetite nanoparticles as a single dose treatment for iron deficiency anemia |
| 04/01/2010 | WO2010034176A1 A throbin-like enzyme of agkistrodon acutus |
| 04/01/2010 | WO2010008995A3 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 04/01/2010 | WO2010005257A3 Controlled-release pharmaceutical preparation containing nicorandil |
| 04/01/2010 | WO2009143064A3 Rice bran extracts for inflammation and methods of use thereof |
| 04/01/2010 | WO2009140246A3 Intraocular drug delivery device and associated methods |
| 04/01/2010 | WO2009139924A3 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 04/01/2010 | WO2009130515A3 Method and system for recording and promoting peripheral nerve regeneration |
| 04/01/2010 | WO2009125981A9 Pharmaceutical formulation |
| 04/01/2010 | WO2009111418A3 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 04/01/2010 | WO2009087675A3 Coated extended release pharmaceutical compositions of levetiracetam |
| 04/01/2010 | WO2009073630A4 Methods and compositons for enhancing the viability of microneedle pores |
| 04/01/2010 | WO2009027697A3 Non-aqueous pharmaceutical compositions |
| 04/01/2010 | WO2009026135A3 Controlled transdermal bisoprolol delivery system |
| 04/01/2010 | WO2009026133A3 Transdermal bisoprolol delivery system |
| 04/01/2010 | WO2008106901A8 A pharmaceutical composition with atorvastatin active ingredient |
| 04/01/2010 | US20100081956 Method, composition, and system to control pH in pulmonary tissue of a subject |
| 04/01/2010 | US20100081715 Bioavailability, and prevents recrystallization of fenofibric acid; dosage forms made by melt extrusion |
| 04/01/2010 | US20100081711 Cytotoxic agents |
| 04/01/2010 | US20100081669 Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis |
| 04/01/2010 | US20100081640 Pharmaceutical composition |
| 04/01/2010 | US20100081609 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/01/2010 | US20100080852 Phamaceutical composition comprising nanoparticles and casein |
| 04/01/2010 | US20100080851 Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule |
| 04/01/2010 | US20100080850 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 04/01/2010 | US20100080849 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same |
| 04/01/2010 | US20100080848 Recombinant Lubricin Molecules and Uses Thereof |
| 04/01/2010 | US20100080847 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same |
| 04/01/2010 | US20100080846 Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
| 04/01/2010 | US20100080845 Cosmetic Methods And Compositions For Repairing Human Skin |
| 04/01/2010 | US20100080844 Method to enhance an immune response of nucleic acid vaccination |
| 04/01/2010 | US20100080843 Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis |
| 04/01/2010 | US20100080842 Transdermal extended-delivery donepezil compositions and methods for using the same |
| 04/01/2010 | US20100080836 Method and means for culturing osteoblastic cells |
| 04/01/2010 | US20100080835 Implantable device for the delivery of risperidone and methods of use thereof |
| 04/01/2010 | US20100080830 Systemic delivery of antiviral agents |
| 04/01/2010 | US20100080829 Lyophilized pharmaceutical compositions and methods of making and using same |
| 04/01/2010 | US20100080823 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 04/01/2010 | US20100080787 Cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium as well as its uses |
| 04/01/2010 | US20100080782 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/01/2010 | US20100080761 Extracts of Isochrysis sp. |
| 04/01/2010 | US20100080760 Method, device, and system to control pH in pulmonary tissue of a subject |
| 04/01/2010 | DE202010001237U1 Kombination aus Tramadol und Acetaminophen als Brausetablette Combination of tramadol and acetaminophen effervescent tablet |
| 04/01/2010 | DE19943491B4 Verbesserte Komprimate Improved compressed |
| 04/01/2010 | DE102008042381A1 Emulgator-Systeme für kosmetische und pharmazeutische Öl-in-Wasser-Emulsionen Emulsifier systems for cosmetic and pharmaceutical oil-in-water emulsions |
| 04/01/2010 | DE102008042220A1 Preparing a solid drug with defined dose of an active substance, comprises preparing an active substance solution, adding determined amount of solution to a solid carrier in a vessel and removing the solvent present in the solution |
| 04/01/2010 | CA2775660A1 Device for photodynamical therapy of cancer |
| 04/01/2010 | CA2740633A1 Mineral-coated microspheres |
| 04/01/2010 | CA2738891A1 Orally-administered agent |
| 04/01/2010 | CA2738855A1 Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
| 04/01/2010 | CA2738414A1 Extended release dosage form of ropinirole |
| 04/01/2010 | CA2738245A1 Nanoemulsion therapeutic compositions and methods of using the same |
| 04/01/2010 | CA2738197A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 04/01/2010 | CA2738128A1 Herbal composition and method for the treatment of viral infection |
| 04/01/2010 | CA2738078A1 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 04/01/2010 | CA2737880A1 Method for manufacturing soft capsule and apparatus for manufacturing the same |
| 04/01/2010 | CA2736259A1 Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation |
| 04/01/2010 | CA2735899A1 Liquid formulations of bendamustine |
| 04/01/2010 | CA2735822A1 Organic acid free effervescent formulation |
| 03/31/2010 | EP2169067A1 Recombinant production of serum albumin |
| 03/31/2010 | EP2168973A1 Nucleic acid ligand complexes |
| 03/31/2010 | EP2168601A1 Spherical mannitol crystal particle |
| 03/31/2010 | EP2168593A1 Oral vaccine compositions |
| 03/31/2010 | EP2168585A1 Pharmaceuticals compositions of a neuroactive steroid and uses thereof |
| 03/31/2010 | EP2168581A2 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 03/31/2010 | EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 03/31/2010 | EP2168575A1 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity |
| 03/31/2010 | EP2168573A1 Formulations comprising ezetimibe |
| 03/31/2010 | EP2168572A1 New controlled release active agent carrier |
| 03/31/2010 | EP2168571A2 Particles for use in a Pharmaceutical Composition |
| 03/31/2010 | EP2168557A2 Production method of gelatin particles |
| 03/31/2010 | EP2167554A1 Biocompatible microgels and applications thereof |
| 03/31/2010 | EP2167209A1 Hollow porous microspheres |
| 03/31/2010 | EP2167154A2 Methods and systems for coating a microneedle with a dosage of a biologically active compound |
| 03/31/2010 | EP2167153A2 Occlusion instruments comprising bioresorbable radiopaque polymeric materials, as well as related products, methods and uses |
| 03/31/2010 | EP2167131A1 Coating formulations including polyphosphazene polyelectrolytes and biologically active agents and asperities coated with such formulations |
| 03/31/2010 | EP2167093A1 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound |
| 03/31/2010 | EP2167071A2 A baclofen solution for low-volume therapeutic delivery |
| 03/31/2010 | EP2167067A1 Use of eflucimibe for the production of a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals |
| 03/31/2010 | EP2167056A2 Transdermal and transmucosal drug delivery enhancers |
| 03/31/2010 | EP2167055A1 Transdermal tobacco alkaloid reservoir patch |
| 03/31/2010 | EP2167054A2 Method for preparing lipid nanoparticles |
| 03/31/2010 | EP2167053A2 Nanocapsules with liquid lipidic core loaded with water-soluble or water-dispersible ingredient(s) |
| 03/31/2010 | EP2167052A2 Biocide capsules, preparation comprising them and sanitary pad comprising the preparation |
| 03/31/2010 | EP2167051A1 Microcapsules containing mammals' spermatozoids, insemination dose containing same and method for obtaining same |